Evidence map›Paper›PMID 29238045›Full record

ArticleCell death & disease2017

RIPK3 promotes adenovirus type 5 activity.

Melanie Weigert, Alex Binks, Suzanne Dowson, Elaine Y L Leung, Dimitris Athineos, Xinzi Yu, Margaret Mullin, Josephine B Walton, Clare Orange, Darren Ennis and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Programmed cell death in triple-negative breast cancer.Cellular & molecular biology letters · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Metabolome-Driven Regulation of Adenovirus-Induced Cell Death.International journal of molecular sciences · 2021
    Review
  11. Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of theInternational journal of molecular sciences · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. The Oncolytic VirusFrontiers in oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Melanie WeigertInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.
Alex BinksInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.ORCID http://orcid.org/0000-0001-5413-9241
Suzanne DowsonInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.ORCID http://orcid.org/0000-0003-2511-1965
Elaine Y L LeungInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.
Dimitris AthineosCancer Research UK Beatson Institute, Glasgow, UK.ORCID http://orcid.org/0000-0001-5298-7941
Xinzi YuInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.
Margaret MullinSchool of Life Sciences, University of Glasgow, Glasgow, UK.
Josephine B WaltonInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.
Clare OrangeInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.
Darren EnnisInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.
Karen BlythInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK.ORCID http://orcid.org/0000-0002-9304-439X
Iain A McNeishInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK. i.mcneish@imperial.ac.uk.ORCID http://orcid.org/0000-0002-9387-7586
University of Glasgow · GBCancer Research UK Scotland Institute · GBCancer Research UK · GB

Funding

Cancer Research UK 15973Cancer Research UK C16420/A12995Cancer Research UK C596/A17196Cancer Research UK C608/A15973Medical Research Council G0501974Medical Research Council G0601891
6 · The paper itself

Abstract

Oncolytic adenoviral mutants infect human malignant cells and replicate selectively within them. This induces direct cytotoxicity that can also trigger profound innate and adaptive immune responses. However, the mechanism by which adenoviruses produce cell death remains uncertain. We previously suggested that type 5 adenoviruses, including the E1A CR2 deletion mutant dl922-947, might induce a novel form of programmed death resembling necroptosis. Here we have investigated the roles of core necrosis proteins RIPK1, RIPK3 and MLKL in the cytotoxicity of dl922-947 and other adenovirus serotypes. By electron microscopy, we show that dl922-947 induces similar necrotic morphology as TSZ treatment (TNF-α, Smac mimetic, zVAD.fmk). However, dl922-947-mediated death is independent of TNF-α signalling, does not require RIPK1 and does not rely upon the presence of MLKL. However, inhibition of caspases, specifically caspase-8, induces necroptosis that is RIPK3 dependent and significantly enhances dl922-947 cytotoxicity. Moreover, using CRISPR/Cas9 gene editing, we demonstrate that the increase in cytotoxicity seen upon caspase inhibition is also MLKL dependent. Even in the absence of caspase inhibition, RIPK3 expression promotes dl922-947 and wild-type adenovirus type 5 efficacy both in vitro and in vivo. Together, these results suggest that adenovirus induces a form of programmed necrosis that differs from classical TSZ necroptosis.

Indexed as

Adenoviruses, HumanAmino Acid Chloromethyl KetonesAnimalsApoptosisBase SequenceCell Line, TumorDNA, ViralFemaleGene Expression RegulationHEK293 CellsHeLa CellsHumansImidazolesIndolesMiceMice, NudeAmino Acid Chloromethyl Ketonesbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneDNA, ViralImidazolesIndolesLCL161MLKL protein, humannecrostatin-1Protein KinasesReceptor-Interacting Protein Serine-Threonine KinasesRIPK1 protein, humanRIPK3 protein, humanThiazolesTumor Necrosis Factor-alpha

Identifiers

PMID29238045
PMCPMC5870599
OpenAlexW2772566954

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.